Medical Imaging-based AI solutions are accelerating and improving drug development pipelines and enabling personalized healthcare. Development of these solutions requires a unified, agile, secure, and collaborative framework spanning the entire data management and AI lifecycle. To streamline and accelerate this process, an end-to-end workflow for data ingestion and curation, annotation and labeling, and model training, validation, and inference is critical.
Attendees will learn how life sciences organizations can accelerate the conversion of complex imaging data into analysis-ready datasets while ensuring regulatory compliance through version control and provenance tracking, propelling medical imaging research, boosting efficiencies, and accelerating drug discovery.
Shelby brings nearly two decades of experience building and leading large cross-functional teams in both scientific and business domains – with a passion and expertise in integrating advanced technologies and imaging science to accelerate drug development and improve patient care. At Flywheel, Shelby is responsible for setting the pharma strategy and priorities as well as driving and enhancing the Field Application and Science team’s impact across life sciences companies, academic medical centers, and healthcare providers. Prior to joining Flywheel, Shelby served various technical, strategic, and operational roles during her 13-year tenure at Genentech / Roche – most recently playing a pivotal role in building and scaling Roche’s Global Imaging Platform and Annotation Solution, both powered by Flywheel. Shelby holds a PhD in Biomedical Engineering / Imaging Science from Vanderbilt University.
Throughout Mike Maker’s career he has worked in all areas of the imaging data life cycle. Mike worked for 9 years at Novartis as an imaging scientist acquiring images and performing analysis. Quickly, he realized the value of automation and was able to reduce turnaround time from days to hours. Mike then worked for Invicro for 6 years, applying his skills to their pharma customers; amplifying his impact. At Flywheel, Mike’s mission is to get tools into the hands of scientists, empowering them to accelerate their findings.
Surani Fernando is a seasoned healthcare journalist and editor with over 13 years experience covering the biopharma industry. A Sydney native, she started her investigative journalism career in London covering clinical trials, M&A and financing deals for BioPharm Insight, later moving to New York to continue her work as an enterprise journalist and editorial leader for GlobalData and Reorg. She is now based in Madrid working as a freelance journalist, consultant writer and podcast producer. In November 2023, she launched the Raising Biotech podcast.